BlackRock Fund Advisors recently announced the acquisition of new stake in OraSure Technologies Inc. (NASDAQ:OSUR). The institutional investor has increased its shareholding in the Healthcare company by 7.49% to 9.58 million shares with purchase of 0.67 million shares. This fresh investment now brings its stake to 13.44% valued currently at $173.9 million. In addition, The Vanguard Group, Inc. raised its holdings by 0.66 million to 4.54 million shares. And Renaissance Technologies LLC has lifted its position by 2.14% or 81340.0 shares – to 3.88 million shares.
With over 2.34 million OraSure Technologies Inc. (OSUR) shares trading Friday and a closing price of $11.69 on the day, the dollar volume was approximately $27.31 million. The shares have shown a negative weekly performance of -20.93% and its price on 08/28/20 gained nearly 1.39%. Currently, there are 71.56M common shares owned by the public and among those 66.55M shares have been available to trade.
An analysis of what Wall Street brokers have to say about the expected price targets for this stock gives us this picture: 7 analysts who have offered their price forecasts for OSUR have a consensus price objective of $18.57. The analysts have set the share’s price value over the next 12 months at a high of $24.00 and a low of $15.00 should the stock experience a downside. Incidentally, analysts’ outlook for the OraSure Technologies Inc. stock is 2.30 for the next 12 months. The average price target is 37.05% above its last price level and an upside to the estimated low will see the stock gain 22.07% over that period. But an upside of 51.29% will see the stock hit the forecast high price target while mean target price for the stock is $18.00.
Insiders at the company have transacted a total of 51 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 23 of these insider trades were purchases, accounting for 394,352 shares. Insider sales of the common stock occurred on 28 occasions, with total insider shares sold totaling 78,762 shares.
The top 3 mutual fund holders in OraSure Technologies Inc. are iShares Core S&P Small Cap ETF, Vanguard Total Stock Market Index, and Fidelity Select Medical Technolog. iShares Core S&P Small Cap ETF owns 4.45 million shares of the company’s stock, all valued at over $80.69 million. The company bought an additional 27944.0 shares recently to bring their total holdings to about 6.24% of the shares outstanding. Vanguard Total Stock Market Index bought 638.0 shares to see its total holdings expand to 1.95 million shares valued at over $35.36 million and representing 2.73% of the shares outstanding. Fidelity Select Medical Technolog sold -0.63 million shares to bring its total holdings to over 1.7 million shares at a value of $30.86 million. Fidelity Select Medical Technolog now owns shares totaling to 2.38% of the shares outstanding.
Shares of OraSure Technologies Inc. (NASDAQ: OSUR) opened at $11.44, down -$0.09 from a prior closing price of $11.53. However, the script later closed the day at $11.69, up 1.39%. The company’s stock has a 5-day price change of -20.93% and -17.21% over the past three months. OSUR shares are trading 45.58% year to date (YTD), with the 12-month market performance up to 72.93% higher. It has a 12-month low price of $5.23 and touched a high of $19.75 over the same period. Currently, 2.34 million shares have been traded, compared to an average intraday trading volume of 2.09 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by -20.85%, -17.41%, and 8.87% respectively.
Institutional ownership of OraSure Technologies Inc. (NASDAQ: OSUR) shares accounts for 97.50% of the company’s 71.56M shares outstanding. Mutual fund holders own 57.00%, while other institutional holders and individual stakeholders account for 8.67% and 44.84% respectively.
It has a market capitalization of $825.08M and a beta (3y monthly) value of 0.52. The earnings-per-share (ttm) stands at -$0.03. Price movements for the stock have been influenced by the stock’s volatility, which stands at 11.90% over the week and 8.48% over the month.
Analysts forecast that OraSure Technologies Inc. (OSUR) will achieve an EPS of -$0.07 for the current quarter, $0.05 for the next quarter and $0.39 for 2021. The lowest estimate earnings-per-share for the quarter is -$0.11 while analysts give the company a high EPS estimate of $0. Comparatively, EPS for the current quarter was $0.21 a year ago. Earnings per share for the fiscal year are expected to increase by 527.00%, and 239.30% over the next financial year. EPS should shrink at an annualized rate of 20.00% over the next five years, compared to 39.30% over the past 5-year period.
If you are looking to buy this stock, then you may note that the average analyst recommendation by 7 brokerage firm advisors rate OraSure Technologies Inc. (OSUR) as a “Moderate Buy” at a consensus score of 2.30. Specifically, 3 Wall Street analysts polled rate the stock as a buy, while 3 of the 7 advise that investors “hold,” and 0 rated it as a “Sell.”
Looking at the support for the OSUR, a number of firms have released research notes about the stock. Evercore ISI stated their Outperform rating for the stock in a research note on August 21, 2020, with the firm’s price target at $22. JP Morgan coverage for the OraSure Technologies Inc. (OSUR) stock in a research note released on August 10, 2020 offered a Neutral rating with a price target of $18. Citigroup was of a view on August 10, 2020 that the stock is Buy, while Raymond James gave the stock Outperform rating on August 07, 2020, issuing a price target of $16. Lake Street on their part issued Buy rating on June 25, 2020.